Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $55.66 Analyst target: $91.56 Upside: 64.50%
BioMarin Pharmaceutical Inc. develops and markets therapies for people with rare diseases and serious and life-threatening medical conditions. The company is headquartered in San Rafael, California.
See the full interactive analysis & chart →Informational only — not investment advice.